Health care stocks were flat to lower pre-bell Wednesday as the iShares Biotechnology ETF (IBB) was unchanged and the Health Care Select Sector SPDR Fund (XLV) was down 0.5% recently.
Medtronic (MDT) shares were up 0.5% after the company reported higher fiscal Q4 non-GAAP earnings and net sales.
Moderna (MRNA) said it has voluntarily withdrawn its Biologics License Application for mRNA-1083, its flu and COVID combination vaccine candidate for adults aged 50 and older. Shares of Moderna were more than 1% higher premarket.
Belite Bio (BLTE) shares were up 0.4% after the company said the US Food and Drug Administration granted breakthrough therapy designation to its Tinlarebant drug for treating Stargardt disease.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。